"Immunotherapy with tumor lysate-pulsed dendritic cells (DCs) effectively control mesothelioma outgrowth, Dutch scientists report in the May 15th American Journal of Respiratory and Critical Care Medicine."
Read the full article.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment